Song-Eun Park

Title: The Innovative Contributions of Song-Eun Park

Introduction

Song-Eun Park is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 2 patents to his name, Park's work is recognized for its potential impact on medical treatments.

Latest Patents

Park's latest patents include two innovative compounds. The first patent is for a crystal polymorph of 8-bromo-2-(1-methylpiperidin-4-ylamino)-4-(4-phenoxyphenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one hydrochloride. This compound is designed to effectively suppress FLT3 and demonstrates excellent stability even in high temperature and humid environments. The second patent involves substituted pyrazoles as LRRK2 inhibitors. This patent discloses a pyrrolo(pyrazolo)pyrimidine compound that shows excellent LRRK2 inhibitory activity, along with methods for manufacturing the compound and its applications in treating degenerative brain diseases.

Career Highlights

Park is currently employed at Oscotec Inc., where he continues to advance his research and development efforts. His work at Oscotec has positioned him as a key player in the pharmaceutical industry, contributing to innovative solutions for complex health issues.

Collaborations

Some of Park's notable coworkers include Jung-Ho Kim and Jang-Sik Choi. Their collaborative efforts have further enhanced the research environment at Oscotec Inc., fostering innovation and creativity in their projects.

Conclusion

Song-Eun Park's contributions to the field of pharmaceuticals through his patents and work at Oscotec Inc. highlight his role as an influential inventor. His innovative compounds have the potential to make significant advancements in medical treatments.